Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Sofosbuvir 400 mg price?Who owns pembrolizumab?Inrebic fedratinib clinical trials emerging therapies myelofibrosis?Afinitor disperz patent?How long is the patent protection on dupixent?
See the DrugPatentWatch profile for Renvela
Renvela is used to help treat high phosphorus levels (hyperphosphatemia) in people with chronic kidney disease (especially those on dialysis) by binding phosphate in the gut so less phosphorus is absorbed.
Renvela contains sevelamer, a non-absorbed phosphate binder. After you take it with meals, it binds dietary phosphate in the gastrointestinal tract and helps lower blood phosphorus levels.
Renvela is prescribed for patients with chronic kidney disease who need to control serum phosphorus, including patients on dialysis.
Renvela is one option among phosphate binders used to manage hyperphosphatemia in kidney disease; other phosphate binders include products based on calcium or other non-calcium binding agents.
No sources were provided in the prompt for this question.
Other Questions About Renvela :